BioHealth News
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
Up to 60,000 patients in the United States may have PPF, with only one approved therapy available SILVER SPRING, Md. & RESEARCH TRIANGLE PARK,…
Read More
BioBuzz: Addimmune Prepares to go Public, Initiate Phase Ib HIV Trial
By Alex Keown | October 31, 2023 - Addimmune, currently American Gene Technologies HIV-focused research, is expected to become a publicly traded company in early 2024 following…
Read More
Johnson & Johnson Innovation Names Awardees in the Advancing Oncology InnoVAtion QuickFire Challenge
October 25th, 2023 – Johnson & Johnson Innovation, in collaboration with Carilion Clinic Innovation, Verge Alliance (with support from City of Roanoke), and Virginia Tech…
Read More
Indo US Bridging Rare Summit Heralds a New Era of Cooperation for Rare Diseases Orphan Drugs Development
The FDA’s Commissioner, Dr. Robert M. Califf, recently visited India and shared his opinion on India’s Unique Opportunity and Important Responsibility as the Pharmacy…
Read More
Unlocking the Future of Stem Cell Research with MSCRF: A Conversation with Ruchika Nijhara, PhD, Executive Director of Maryland Stem Cell Research Fund (MSCRF)
Are you curious about the world of transformative regenerative medicine and stem cell research? Are you eager to understand how Maryland champions researchers and…
Read More
QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System
Partnership combines QIAGEN’s QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element’s AVITI System users in genomic analysis Collaboration to accelerate discovery,…
Read More
ATCC and USP Launch First Set of Products to Advance Quality and Reduce Risk in the Development of Biological Therapeutics and Vaccines
Six new products that can be used to detect residual host cell genomic DNA (gDNA) MANASSAS, Va. and ROCKVILLE, Md., Oct. 30, 2023 /PRNewswire/ -- Today, ATCC and U.S. Pharmacopeia…
Read More
BioHealth Innovation Inc. (BHI) Announces the Addition of New Technical Writer and Program Manager, Jon Nelson
ROCKVILLE, MARYLAND, October 30, 2023 – BioHealth Innovation Inc. (BHI) proudly welcomes Jon Nelson to its innovative team. Jon joins BHI as a Technical…
Read More
BRAINBox Solutions Announces Initial Series B Investments to Support U.S. Regulatory Clearance, Initial Commercialization of BRAINBox TBI Concussion Diagnostic/Prognostic Test
RICHMOND, Va., Oct. 30, 2023 /PRNewswire/ -- BRAINBox Solutions today announced initial investments into the company's Series B financing to support U.S. regulatory clearance and initial commercialization…
Read More
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023 06:00 AM Eastern Daylight Time - SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. & EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR)…
Read More
FDA approves muscular dystrophy drug built on Children’s National research
WASHINGTON, D.C., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Boys with Duchenne muscular dystrophy (DMD) have a clinically proven, new treatment option with the Food…
Read More
Unveiling the Future of Viral Safety: The 2024 PDA Virus Conference in Amsterdam
Dive into the world of viral safety with the upcoming 2024 PDA Virus Conference. Set against the picturesque backdrop of Amsterdam, this event promises…
Read More
Gaithersburg’s Georgiamune and Verily Announce Strategic Partnership to Advance Novel Cancer Treatment
GAITHERSBURG, Md. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company, today…
Read More
Altimmune Granted Fast Track Designation by FDA for Pemvidutide for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
GAITHERSBURG, Md., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)…
Read More
Centers for Medicare & Medicaid Services Awards MITRE New Five-Year Contract to Continue Operating Health R&D Center
MCLEAN, Va. & BEDFORD, Mass.--(BUSINESS WIRE)--MITRE announced a new five-year contract with the Centers for Medicare & Medicaid Services (CMS) to operate the CMS…
Read More